Total submissions: 3
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Laboratory of Diagnosis and Therapy of Lysosomal Disorders, |
RCV001291009 | SCV005089255 | pathogenic | Mucopolysaccharidosis, MPS-II | 2024-06-07 | criteria provided, single submitter | literature only | Null variant (PVS1_VeryStrong), Absent from controls (or at low frequency) in gnomAD database (PM2_Moderate), Patient’s phenotype or family history highly specific for the disease (PP4_Strong) |
| Dasa | RCV001291009 | SCV002097272 | pathogenic | Mucopolysaccharidosis, MPS-II | 2022-02-14 | criteria provided, single submitter | clinical testing | The c.814C>T;p.(Gln272*) variant creates a premature translational stop signal in the IDS gene. It is expected to result in an absent or disrupted protein product - PVS1. This sequence change has been observed in affected individual(s) and ClinVar contains an entry for this variant (ClinVar ID: 988685) - PS4. This variant is not present in population databases (gnomAD; ABraOM no frequency - http://abraom.ib.usp.br/) - PM2. In summary, the currently available evidence indicates that the variant is pathogenic. |
| Laboratory of Inherited Metabolic Diseases, |
RCV001291009 | SCV001450612 | pathogenic | Mucopolysaccharidosis, MPS-II | no assertion criteria provided | research |